Cefic is committed to ensuring that the health of workers and the safety of products are top priorities for the chemical industry. This paper focuses on the management of substances with respiratory sensitising potential.
Cefic’s position paper from June 2016 addresses the classification of respiratory sensitisers in Europe as Substances of Very High Concern (SVHCs) under REACH regulation. Cefic argues this categorisation is inappropriate and unnecessary, as respiratory sensitisers do not present the same health risks as carcinogens, mutagens, and reproductive toxicants (CMRs). Cefic stresses the reversibility of effects from respiratory sensitisers and emphasises the importance of case-by-case assessment rather than a blanket SVHC designation. Effective management and exposure control can mitigate risks, ensuring worker safety and maintaining quality of life.
Key takeaways:
- Respiratory sensitisation effects are generally reversible, unlike the irreversible consequences of CMRs.
- Managing exposure and applying risk mitigation measures are essential in preventing and reversing allergic symptoms caused by respiratory sensitisers.
- Blanket SVHC classification for respiratory sensitisers could stigmatise substances without substantial added safety benefits, impacting the market and neglecting case-specific risk assessments.